Equity Incentive Plan (Tables)

3 Months Ended

Mar. 31, 2024

Equity Incentive Plan

Schedule of stock option activity

		Average		Remaining
	Number	Exercise		Contract	Intrinsic
	of Shares	Price		Life (Years)	Value
Outstanding at January 1, 2024	426	$	6,103.81	8.53	$	—
Assumed from IMGX	200,652		0.81	7.56		716,328
Outstanding at March 31, 2024	201,078	$	13.74	7.56	$	716,350
Exercisable at March 31, 2024	201,054	$	11.99	7.56	$	716,341
Outstanding at January 1, 2023	176	$	15,956.72	8.22	$	—
Granted	250		74.60	9.91		—
Outstanding at March 31, 2023	429	$	8,900.40	9.07	$	—
Exercisable at March 31, 2023	200	$	17,091.40	8.40	$	—

Schedule of option pricing model with the following weighted-average assumptions

	2024		2023
Contractual term (in years)	7.6		6.5
Expected Volatility	110.35	%	98.80	%
Risk-free interest rate	4.20	%	4.08	%
Expected Dividend yield	0	%	0	%

Schedule of RSU activity under the 2020 Plan

		Weighted-Average		Weighted-Average
	Number	Grant Date		Remaining Recognition
	of Shares	Fair Value		Period (Years)
Non-vested Outstanding at January 1, 2024	52,271	$	4.31	9.96
Awarded	120,532		3.80	—
Vested	(52,271)		4.31	—
Non-vested Outstanding at March 31, 2024	120,532	$	3.82	9.76
Non-vested Outstanding at January 1, 2023	—		—	—
Awarded	7,997	$	124.00	—
Vested	(2,003)		124.00	—
Non-vested Outstanding at March 31, 2023	5,994	$	124.00	0.75

Schedule of stock-based compensation expense

	Three Months Ended March 31,
	2024		2023
Research and development	$	42,378	$	38,080
General and administrative		228,982		320,236
Total stock-based compensation expense	$	271,360	$	358,316